The Role of MicroRNAs in Colorectal Cancer
- 1 May 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Cancer Journal
- Vol. 18 (3), 244-252
- https://doi.org/10.1097/ppo.0b013e318258b78f
Abstract
During the last decade, it has become clear that aberrant microRNA expression has a functional role in the initiation and progression of colorectal cancer (CRC). Specific microRNAs can act as either tumor suppressors or oncogenes depending on the cellular environment in which they are expressed. The expression of microRNAs is reproducibly altered in CRC, and their expression patterns are associated with diagnosis, prognosis, and therapeutic outcome in CRC. Studies have begun to examine the association of microRNA-related polymorphisms and their association with CRC incidence and prognosis as well as the possibility of using circulating microRNAs or fecal microRNA expression as noninvasive early detection biomarkers. These data suggest that microRNAs may be potential molecular classifiers, early detection biomarkers, and therapeutic targets for CRC. Here, we will review the evidence demonstrating a role of microRNAs in CRC.Keywords
This publication has 112 references indexed in Scilit:
- Prognostic Significance of miR-215 in Colon CancerClinical Colorectal Cancer, 2011
- Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancerBritish Journal of Cancer, 2011
- High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patientsClinical & Experimental Metastasis, 2010
- Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 geneCancer, 2010
- MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cellsExperimental Cell Research, 2009
- Small‐Molecule Inhibitors of MicroRNA miR‐21 FunctionAngewandte Chemie, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal CancerOncology, 2007
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- MicroRNA expression profiles classify human cancersNature, 2005